Prothena Corp Public (PRTA) Depreciation & Amortization (CF) (2012 - 2026)

Prothena Corp Public (PRTA) recorded quarterly Depreciation & Amortization (CF) of $184000.0 in Q1 2026, down 15.6% quarter-over-quarter from $218000.0 in Q4 2025, and down 17.49% on a YoY basis from $223000.0 in Q1 2025.

Prothena Corp Public (PRTA) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

Prothena Corp Public's Depreciation & Amortization (CF) history runs 15 years deep, the most recent figure standing at $184000.0 for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) fell 17.49% year-over-year to $184000.0; the TTM figure through Mar 2026 stood at $856000.0 (down 4.99% YoY), while the FY2025 annual figure was $895000.0, changed 0.22% from the prior year.
  • Depreciation & Amortization (CF) was $184000.0 for Q1 2026 at Prothena Corp Public, down from $218000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $276000.0 in Q4 2023 to a low of $182000.0 in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $214352.9 across 5 years, with a median of $221000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) tumbled 40.13% in 2022, then surged 40.82% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $196000.0 in 2022, then soared by 40.82% to $276000.0 in 2023, then slipped by 19.93% to $221000.0 in 2024, then dropped by 1.36% to $218000.0 in 2025, then slipped by 15.6% to $184000.0 in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $184000.0 (Q1 2026), $218000.0 (Q4 2025), and $229000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 429,663.65
10 Prothena Corp Public 479.08 Mn 149.61 Mn - 184,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 184,000.00
Mar 31, 2026 184,000.00
Dec 31, 2025 218,000.00
Dec 31, 2025 218,000.00
Sep 30, 2025 229,000.00
Sep 30, 2025 229,000.00
Jun 30, 2025 225,000.00
Jun 30, 2025 225,000.00
Mar 31, 2025 223,000.00
Mar 31, 2025 223,000.00
Dec 31, 2024 221,000.00
Dec 31, 2024 221,000.00
Sep 30, 2024 226,000.00
Sep 30, 2024 226,000.00
Jun 30, 2024 231,000.00
Jun 30, 2024 231,000.00
Mar 31, 2024 215,000.00
Mar 31, 2024 215,000.00
Dec 31, 2023 276,000.00
Dec 31, 2023 276,000.00